Vaxart Inc (VXRT)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit Dividendenhistorie

Vaxart Inc Aktie (VXRT) Neueste Nachrichten

Vaxart Inc (VXRT)

Vaxart Inc Aktie (VXRT) Neueste Nachrichten

Vaxart Solicits Proxies from Shareholders - marketscreener.com

[DFAN14A] Vaxart, Inc. SEC Filing - Stock Titan

Vaxart Mails a Letter to Shareholders - marketscreener.com

Vaxart Urges Shareholders to Vote “FOR” ALL Six of the Company’s Highly Qualified Director Nominees on the WHITE Proxy Card TODAY - Yahoo Finance

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Vaxart (VXRT) Investors of Securities Fraud Class Action and Encourages Investors with Significant Losses to Contact the Firm, Application Deadline Approaching - TMX Newsfile

Vaxart Files Definitive Proxy Statement and Mails Letter to Shareholders - The Manila Times

Vaxart Shareholder Alert - TMX Newsfile

Vaxart (NASDAQ: VXRT) Board rebuffs activist slate in contested proxy - Stock Titan

Vaxart director Mark Watson buys $6,530 in company stock By Investing.com - Investing.com South Africa

Vaxart director Mark Watson buys $6,530 in company stock - Investing.com UK

Vaxart, Inc. (VXRT) director adds 10,000 shares in open‑market buy - Stock Titan

Vaxart | 4: Statement of changes in beneficial ownership of securities-Officer Lo Steven - Moomoo

Daniel P. Houle Solicits Proxies from Shareholders of Vaxart - marketscreener.com

Activist group (VXRT) with 1.52M shares seeks majority on Vaxart board via GOLD proxy - Stock Titan

Vaxart (NASDAQ: VXRT) CFO uses 31,395 shares to cover RSU taxes - Stock Titan

Vaxart faces proxy contest ahead of July annual meeting By Investing.com - Investing.com Australia

Vaxart, Inc Provides Information to the Shareholders - marketscreener.com

Vaxart Emphasizes Board Stability and Oral Vaccine Platform Progress Ahead of 2026 Shareholder Vote - Minichart

Vaxart faces proxy contest ahead of July annual meeting - Investing.com UK

Vaxart Urges Shareholder Support Amid Proxy Contest, Updates Pipeline - TipRanks

VXRT: Oral pill vaccine platform advances with strong clinical data and extended financial runway - TradingView

Vaxart (NASDAQ: VXRT) proxy fight — Board backs six nominees, urges WHITE card - Stock Titan

Vaxart files preliminary proxy, urges support for board as Phase 2b COVID readout, $61M cash runway into Q2 2027 - TradingView

Vaxart (VXRT) readies contested 2026 vote as trial advances and runway extends to 2027 - Stock Titan

Vaxart (VXRT) registers 32.9M shares; up to $25M of issuer financing - Stock Titan

Vaxart Files Preliminary Proxy Statement and Issues Open Letter to Shareholders - GlobeNewswire

[EFFECT] Vaxart, Inc. SEC Filing - Stock Titan

[S-1/A] Vaxart, Inc. Amends IPO Registration Statement - Stock Titan

Vaxart (VXRT) Institutional Ownership 2026 $VXRT - MarketBeat

Complete Defense Verdict in Rare Securities Class Action Trial - Cornerstone Research

MSN Money - MSN

Vaxart anticipates early 2027 primary efficacy readout while aiming for Q2 sentinel data release - MSN

Earnings call transcript: Vaxart’s mixed Q1 2026 results, EPS beats forecast - Investing.com India

Vaxart (VXRT) Reports Progress in Clinical Programs and Financia - GuruFocus

VXRT: Revenue surged and net income turned positive as clinical milestones and funding flexibility advanced - TradingView

Earnings call transcript: Vaxart’s mixed Q1 2026 results, EPS beats forecast By Investing.com - Investing.com South Africa

VXRT: Revenue doubled year-over-year, with clinical milestones and cash runway into Q2 2027 - TradingView

[S-1] Vaxart, Inc. Files IPO Registration Statement - Stock Titan

Vaxart Q1 2026 Earnings Call Transcript - MarketBeat

Vaxart : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q) - marketscreener.com

VXRT: Returned to profitability in Q1 2026 with strong revenue growth and improved cash position - TradingView

Vaxart targets Q2 data from 400-person oral COVID vaccine study - Stock Titan

Vaxart Provides Business Update and Reports First Quarter 2026 Financial Results - The Manila Times

Vaxart, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

Vaxart (OTCQX: VXRT) swings to Q1 2026 profit on BARDA and collaboration revenue - Stock Titan

Vaxart (OTCQX: VXRT) swings to Q1 2026 profit as COVID trial advances - Stock Titan

Vaxart (VXRT) files ATM supplement to raise up to $49.8M via Sales Agents - Stock Titan

Ähnlich wie VXRT